Abstract:A series of some new ciprofloxacin‐benzimidazole hybrids were synthesized and investigated for their antimicrobial activities against Gram‐positive and Gram‐negative bacteria. Most of the synthesized compounds were found to show better or equivalent activities when compared with the standard drug ciprofloxacin. Results were confirmed by a molecular docking study against S. aureus DNA gyrase. Also, ADMET properties were also calculated. These were found to be within an acceptable range of 95 % drug molecules. In this study, we designed and synthesized some new ciprofloxacin‐benzimidazole hybrid compounds and evaluated them for their antimicrobial activity against four Gram‐positive (B. subtilis, B. megaterium, E. faecalis and S. aureus) and five Gram‐negative (E. coli, E. cloacae, P. aeruginosa, S. typhimurium and Y. pseudotuberculosis) bacteria. Most of the synthesized compounds were found to show better or equivalent activities when compared with the standard drug ciprofloxacin. Among the tested compounds, compounds 4 v and 4 w showed more or the same activities against most of the bacteria. In the light of the information obtained from this study, the results showed that the synthesized hybrid compounds could be potential antibiotic agents. Antimicrobial activities were also confirmed by molecular docking studies against active site of Staphylococcus aureus DNA gyrase. Based on docking results, the compound 4e‐protein complex having the best score was used to perform 100 ns MD simulations to analyze the dynamic behavior and stability of the complex. Furthermore, the active compounds demonstrated acceptable ranges of ADMET properties such as partition coefficients, cellular permeability, and toxicity values.

Synthesis and in vitro antibacterial activity of N-acylarylhydrazone-ciprofloxacin hybrids as novel fluoroquinolone derivatives

Discovery of Benzimidazole–Quinolone Hybrids As New Cleaving Agents Toward Drug‐Resistant Pseudomonas Aeruginosa DNA

Antibacterial and anti-biofilm activities of new fluoroquinolone derivatives coupled with nitrogen-based heterocycles

Design, Synthesis, and Evaluation of Novel Fluoroquinolone-Flavonoid Hybrids As Potent Antibiotics Against Drug-Resistant Microorganisms.

Novel Synthesis Of Arylfluoroquinolone Antimicrobial Agents

Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities

Novel antimicrobial ciprofloxacin-pyridinium quaternary ammonium salts with improved physicochemical properties and DNA gyrase inhibitory activity

Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents

Multi-Targeting Exploration of New 2-Aminothiazolyl Quinolones: Synthesis, Antimicrobial Evaluation, Interaction with Dna, Combination with Topoisomerase Iv and Penetrability into Cells

Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.

Design, synthesis and anti-TB and anti-bacterial activity of Ciprofloxacin derivatives containing N-(amino)piperazine moieties

[Synthesis and anti-proliferative activity of fluoroquinolone C-3 fused heterocyclic α,β-unsaturated ketones derived from ciprofloxacin]

1,2,4-Triazole-conjugated Fluoroquinolones as Potential Candidates for New Antibacterial Agents

Design and Synthesis of Novel Desfluoroquinolone-Aminopyrimidine Hybrids As Potent Anti-Mrsa Agents with Low Herg Activity

Developing Effective Antimicrobial Agents: Synthesis and Molecular Docking Study of Ciprofloxacin‐Benzimidazole Hybrids

Design, Synthesis, Antibacterial Evaluation and Docking Study of Novel 2‐hydroxy‐3‐(nitroimidazolyl)‐propyl‐derived Quinolone

Synthesis and antibacterial activity evaluation of N (7) position-modified balofloxacins

Novel heterocyclic 1,3,4-oxadiazole derivatives of fluoroquinolones as a potent antibacterial agent: Synthesis and computational molecular modeling

Novel Benzothiazole‒urea Hybrids: Design, Synthesis and Biological Activity As Potent Anti-Bacterial Agents Against MRSA.

Design, synthesis, and antibacterial evaluation of novel azolylthioether quinolones as MRSA DNA intercalators

Antibiofilm and Anti-Quorum-Sensing Activities of Novel Pyrazole and Pyrazolo[1,5-a]pyrimidine Derivatives as Carbonic Anhydrase I and II Inhibitors: Design, Synthesis, Radiosterilization, and Molecular Docking Studies